Virtu Financial’s CERo Therapeutics Warrants CEROW Stock Holding History

Virtu Financial’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21,104	Closed	–	–	2336
2025 Q3	$0	Buy	21,104 +630	+3%	+$11	﹤0.01%	2187
2025 Q2	$0	Buy	+20,474	New	+$317	﹤0.01%	2116
2022 Q3	–	Sell	-15,814	Closed	-$2K	–	2307
2022 Q2	$2K	Buy	15,814 +2	+0%	–	﹤0.01%	1493
2022 Q1	$3K	Sell	15,812 -567	-3%	-$211	﹤0.01%	1409
2021 Q4	$7K	Buy	+16,379	New	+$7.55K	﹤0.01%	1592

Other funds holding CEROW

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Virtu Financial's CEROW Position: Q4 2025 in Review

Virtu Financial sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 21,104 shares.

Virtu Financial first reported a position in CEROW in Q4 2021 and held it in 5 quarters. The position peaked at $7K in Q4 2021. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

Virtu Financial reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 21,104 CERo Therapeutics Warrants shares in Q4 2025.
Virtu Financial first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 5 quarters.
Virtu Financial's CERo Therapeutics Warrants position peaked at $7K in Q4 2021.
1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.